EGFR and periodontitis: Previous research has revealed that bacterial components in the inflammatory microenvironment can activate the epidermal growth factor receptor (EGFR) on BMSCs.[12] EGFR, a key regulator in the ErbB signaling pathway, negatively influences osteoblastic differentiation,[13, 14] identifying it as a potential therapeutic target for periodontitis.